Category Archives: General HIV+ population

Reviews on HIV+ people where the population is not specified

A critical evaluation of the therapeutic range of indinavir

2002

OBJECTIVE: To provide a summary of the patient population, study characteristics, and important findings of the key studies in the literature evaluating concentration-effect relationships and the therapeutic range for indinavir....

Is the sexual behaviour of HIV patients on antiretroviral therapy safe or risky in Sub-Saharan Africa? Meta-analysis and meta-regression

2012

Background: Reports on the sexual behavior of people on antiretroviral therapy (ART) are inconsistent. We selected 14 articles that compared the sexual behavior of people with and without ART for...

Role of therapeutic drug monitoring for protease inhibitors

2001

OBJECTIVE: To review the role of therapeutic drug monitoring (TDM) for protease inhibitors in the treatment of HIV infection. DATA SOURCES: Primary articles were identified using MEDLINE (1966-October 2000), EMBASE...

Valganciclovir: An advance in cytomegalovirus therapeutics

2002

OBJECTIVE: To review the pharmacology, pharmacokinetics, and preliminary clinical data for valganciclovir, a new oral agent for the therapy of cytomegalovirus (CMV) retinitis. DATA SOURCES: Relevant literature was extracted via...

Might infection explain the higher risk of coronary heart disease in South Asians? Systematic review comparing prevalence rates with white populations in developed countries

2012

OBJECTIVES: South Asians in developed countries such as the UK are at comparatively high risk of coronary heart disease for reasons which are not fully understood. One unexplored hypothesis is...

Drug-related hypertension and resistance to antihypertensive treatment: A call for action

2011

Several drugs can cause hypertension and/or blunt the effect of antihypertensive treatment. They can exacerbate a previously well controlled hypertension and/or render it resistant to therapy. Accordingly, drugs represent a...

A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging

2011

PURPOSE: HIV-related immunological and multisystem accelerated aging contributes to the premature occurrence of age-related comorbidities. Such non-AIDS-defining comorbidities include cardiovascular disease, dyslipidemia, osteoporosis and frailty, and are of increasing importance...

Levels of adherence required for virologic suppression among newer antiretroviral medications

2011

OBJECTIVE: To determine the adherence levels needed for HIV virologic suppression with newer antiretroviral (ARV) medications, including darunavir, etravirine, and raltegravir. DATA SOURCES: Literature searches of PubMed, MEDLINE (1950-October 2010),...

Analysis of neuropsychiatric adverse events during clinical trials of efavirenz in antiretroviral-naive patients: A systematic review

2010

People with HIV infection have several risk factors for developing neuropsychiatric adverse events: preexisting conditions, HIV disease stage, and antiretroviral treatment. The most widely used system for assessing neuropsychiatric adverse...

Social and behavioural HIV/AIDS research in Jordan: A systematic review

2012

This systematic review evaluated the extent of HIV/AIDS research conducted in Jordan related to behavioural and/or social outcomes. MEDLINE, CINAHL, PsycINFO and OVID (1980-2009) were searched as well as the...

What is the evidence for effectiveness of interventions to enhance coping among people living with HIV disease? A systematic review

2011

As new treatments enhance mortality, and infection rates continue to grow in many communities, the concept of “living well” with human immunodeficiency virus (HIV) infection is essential. The concept of...

Behavioural interventions for HIV positive prevention in developing countries: A systematic review and meta-analysis

2010

Objective To assess the evidence for a differential effect of positive prevention interventions among individuals infected and not infected with human immunodeficiency virus (HIV) in developing countries, and to assess...

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!